Maternal and foetal angiogenic imbalance in congenital heart defects

European Heart Journal

Volumn 35, Issue 11, 2014, Pages

  Llurba, Elisa ^a,b,c   Sánchez, Olga ^b,c   Ferrer, Queralt ^a   Nicolaides, Kypros H ^d,e   Ruíz, Aina ^a,b   Domínguez, Camen ^a,c   Sánchez De Toledo, Joan ^a   García García, Belén ^a,b   Soro, Gemma ^a,b   Arévalo, Silvia ^a   Goya, Maria ^a,b   Suy, Anna ^a,b   Pérez Hoyos, Santiago ^a   Alijotas Reig, Jaume ^a   Carreras, Elena ^a,b   Cabero, Lluís ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Congenital heart defects; Placental growth factor; sFlt 1; Soluble endoglin; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; FETUS; FETUS BLOOD; FETUS CIRCULATION; GENE EXPRESSION; HEART; HUMAN; HUMAN TISSUE; HYPOXIA; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL CIRCULATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD;

CONGENITAL HEART DEFECTS; PLACENTAL GROWTH FACTOR; SFLT-1; SOLUBLE ENDOGLIN; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; FETUS; HEART DEFECTS, CONGENITAL; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY PROTEINS; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84898975391     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht389     Document Type: Article

References (47)

1. vander LindeD,KoningsEEM,SlagerMA,WitsenburgM,HelbingWA,TakkenbergJJM, Roos-Hesselink JW. Birth prevalence of congenital heart diseaseworldwide: A systematic review and meta-Analysis. J Am Coll Cardiol 2011;58:2241-2247
2. Office for National Statistics. Mortality Statistics. Childhood, infancy and perinatal. Series DH3. 2002;35
3. Mitchell ME, Sander TL, Klinkner DB, Tomita-Mitchell A. The Molecular basis of congenital heart disease. Semin Thorac Cardiovasc Surg 2007;19:228-237. (Pubitemid 350047380)
4. Srivasrava D. Making or breaking the heart: From lineage determination to morphogenesis. Cell 2006;126:1037-1048
5. Romero R, kusanovic JP, Chaiworapongsa T, Hassan SS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruption placentae. Best Pract Clin Obstet Gynecol 2011;25:313-327
6. ShoreVH,Wang TH,Wang CL, Torry RJ, Caudle MR, Torry DS. Vascularendothelial growth factor, placental growth factor and their receptors in isolatedhuman trophoblast. Placenta 1997;18:657-665. (Pubitemid 27448423)
7. Zieche M, Maglione D, Ribatti D. Placenta growth factor-I is chemotactic, mitogenic, and angiogenic. Lab Invest 1997;76:517-531. (Pubitemid 27176106)
8. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31:66-74
9. Ferrara N, Caver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hilla KJ, MooreMW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442
10. Lee YM, CopeJJ, Ackermann GE, Goishi K, Armstrong EJ, PawBH, Bischoff J. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Dev Dyn 2006;235:29-37. (Pubitemid 46939700)
11. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Pro Natl Acad Sci USA 1991;88:9267-9271. (Pubitemid 21915612)
12. Llurba E, Syngelaki A, Sánchez O, Carreras E, Cabero L, Nicolaides K. Maternal serum placental growth factor at 11-13 weeks' gestation and foetal cardiac defects. Ultrasound Obstet Gynecol 2013;2:169-174
13. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, PostM, Bocking A, TodrosT, Caniggia I. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008;93:285-292
14. Parra-Cordero M, Lees C, Missfelder-Lobos H, Seed P, Harris C. Fetal arterial and venous Doppler pulsatility index and time averaged velocity ranges. Prenat Diagn 2007;27:1251-1257. (Pubitemid 350305443)
15. Gomez O, Figueras F, Fernandez S, Bennasar M, Martinez JM et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128-132
16. Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH. A competing risks model in early screening for preeclampsia. Foetal Diagn Ther 2012;32:171-178
17. Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH. Maternal serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks' gestation. Foetal Diagn Ther 2012;31:87-93
18. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000;127:3941-3943946
19. Bussmann J, Bakkers J, Schulte-Merker S. Early endocardial morphogenesis requires Scl/Tal 1. Plos Genet 2007;3:e140
20. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-583. (Pubitemid 32448325)
21. Accornero F, Molkentin JD. PlacentalGrowth Factor (PGF) as a protective paracrine effector in the heart. Trends Cardiovasc Med 2011;21:220-224
22. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007;11: 335-347. (Pubitemid 46518312)
23. Druyan S, Cahaner A, Ashwell CM. The expression patterns of hypoxia-inducing factor subunit alpha-1, heme oxygenase, hypoxia upregulated protein 1, and cardiac troponin T during development of the chicken heart. Poult Sci 2007;86:2384-2389. (Pubitemid 350097223)
24. Armstrong EJ, Bischoff J. Heart valve development: Endothelial cell signaling and differentiation. JCirc Res 2004;95:459-470. (Pubitemid 39180926)
25. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-436. (Pubitemid 24349853)
26. McBride KL, Zender GA, Fitzgerald-Butt SM, Koehler D, Menesses-Diaz A, Fernbach S, Lee K, Towbin JA, Leal S, Belmont JW. Linkage anaylisis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome. Eur J Hum Genet 2009;17:811-819
27. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437: 270-274. (Pubitemid 41294491)
28. McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TM. III Novel NOTCH1mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007;134:290-296. (Pubitemid 47088578)
29. McBride KL, Riley MF, Zender GA, Fitzgerald-Butt SM, Towbin JA, Belmont JW, Cole SE. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 2008;17:2886-2893
30. Hitz M-P, Lemieux-Perreault L-P, Marshall C, Feroz-Zada Y, Davies R, Yang SW, Lionel AC, D'Amours G, Lemyre E, Cullum R, Bigras JL, Thibeault M, Chetaille P, Montpetit A, Khairy P, Overduin B, Klaassen S, Hoodless P, Awadalla P, Hussin J, Idaghdour Y, Nemer M, Stewart AF, Boerkoel C, Scherer SW, Richter A, Dubé MP, Andelfinger G. Rare Copy Number Variants Contribute to Congenital Left-Sided HeartDisease. PLoS Genet 2012;8:e1002903. doi:10.1371/journal.pgen.1002903
31. Spiers PS,Wang L. Short pregnancy interval, low birthweight, and the sudden infant death syndrome. Am J Epidemiol 1976;104:15-21
32. Rosenthal GL, Wilson PD, PermuttT, Boughman JA, Ferencz C. Birth weight and cardiovascular malformations: A population-based study. The Baltimore-Washington Infant Study. Am J Epidemiol 1991;133:1273-1281
33. Kaltman JR, Di H, Tian Z, Rychik J. Impact of congenital heart disease on cerebrovascular blood flow dynamics in the fetus. Ultrasound Obstet Gynecol 2005;25:32-36. (Pubitemid 40128900)
34. DonofrioMT, Bremer YA, Schieken RM, Gennings C, Morton ID, EidemBW, Cetta F, Falkensammer CB, Huhta JC, Kleinman CS. Autoregulation of cerebral blood flow in fetuses with congenital heart disease: The brain sparing effect. Pediatr Cardiol 2003;24: 436-443. (Pubitemid 36993509)
35. Berg C, Gembruch O, Gembruch U, Eipel A. Doppler indices of the middle cerebral artery in fetuses with cardiac defects theoretically associated with impaired cerebral oxygen delivery in utero: Is there a brain-sparing effect?. Ultrasound Obstet Gynecol 2009;34:666-672
36. Modena A, Horan C, Visintine J, Chanthasenanont A,Wood D,Weiner S. Fetuses with congenital heart disease demonstrate signs of decreased cerebral impedance. Am J Obstet Gynecol 2006;195:706-710. (Pubitemid 44292125)
37. Szwast A, Tian Z, McCann M, Soffer D, Rychik J. Comaparative analysis of cerebrovascular resistence in fetuses with single-ventricle congenital heart disease. Ultrasound Obstet Gynecol 2012;40:62-67
38. ArduiniM, Rosati P, Cafori L, Guariglia L, Clerici G, Di Renzo GC, Scambia G. Cerebral blood flow autoregulation and congenital heart disease: Possible causes of abnormal prenatal neurologic development. J Matern Fetal and Neonatal Med 2011; 24:1208-1211
39. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999;5:495-502. (Pubitemid 29220207)
40. Kirk R. Bevacizumab and heart failure. Nat Rev Clin Oncol 2011;8:124
41. Uraizee I, Cheng S, Moslehi J. Reversible cardiomyopathy associated with sunitinib and sorafenib. N Engl J Med 2011;365:1649-1650
42. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485: 333-338
43. Khurana R, Moons L, Shafi S, Luttun A, Collen D, Martin JF, Carmeliet P, Zachary IC. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 2005;111:2828-2836. (Pubitemid 40791556)
44. Hochholzer W, Reichlin T, Stelzig C, Hochholzer K, Meissner J, Breidthardt T, Reiter M, Duehsler B, Freidank H, Winkler K, Twerenbold R, Mueller C. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur Heart J 2011;32:326-335
45. Wieczorek A, Hernandez-Robles J, Ewing L, Leshko J, Luther S, Huhta J. Prediction of outcomeof foetal congenital heart disease using a cardiovascular profile score. Ultrasound Obstet Gynecol 2008;31:284-288
46. Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL Jr, Guizard N, McGrath E, Geva J, Annese D, Dunbar-Masterson C, Trainor B, Laussen PC, du Plessis AJ. Brain volume and metabolism in fetuses with congenital heart disease: Evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 2010;121:26-33
47. MahleWT, Tavsni F, Zimmerman RA, Nicolson SC, Galli KK, GaynorJW, Clancy RR, Montenegro LM, Spray TL, Chiavacci RM,Wernovsky G, KurthCD.An MRI study of neurological injury before and after congenital heart surgery. Circulation 2002;106: 1109-1114